Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Finkemeier

Orthopaedic Surgery Carmichael, CA Medical Doctor

NPI 1619990710 CMS profile 27564

6620 Coyle Ave, Ste 212, Carmichael, CA 95608

Open in the dashboard

General payments

$358,409

283 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Finkemeier of Carmichael, CA is reported in the CMS Open Payments database as having received $358,409 across 283 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,444 34
2024 General $116,534 62
2023 General $41,048 33
2022 General $90,864 54
2021 General $30,967 24
2020 General $21,865 27
2019 General $52,686 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Finkemeier
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Christopher Finkemeier were reported at $4,444. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Christopher Finkemeier Orthopaedic Surgery median Middle half National median
2019 $52,686 $644 $140–$2,844 $163
2020 $21,865 $312 $75–$1,860 $114
2021 $30,967 $520 $117–$2,495 $132
2022 $90,864 $598 $128–$2,731 $149
2023 $41,048 $461 $128–$2,264 $160
2024 $116,534 $497 $134–$2,475 $164
2025 $4,444 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $290,749 147 payments
  2. Synthes GmbH $55,329 63 payments
  3. OsteoCentric Technologies, Inc. $9,191 29 payments
  4. DePuy Synthes Sales Inc. $2,510 33 payments
  5. LifeNet Health $169 1 payment
  6. IlluminOss Medical, Inc. $125 2 payments
  7. Evolution Surgical, Inc $122 1 payment
  8. Stryker Corporation $84 1 payment
  9. Acell, Inc. $41 2 payments
  10. Integra LifeSciences Corporation $28 1 payment
  11. Other $63 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $245,660 40 payments
  2. Travel and Lodging $68,077 79 payments
  3. Honoraria $23,833 35 payments
  4. Food and Beverage $6,268 99 payments
  5. Royalty or License $5,941 25 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $4,380 2 payments
  7. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $4,250 3 payments
Products named General payments · program years 2019–2025
  1. NA Trauma $224,832 81 payments
  2. NA Trauma $224,755 79 payments
  3. DHS $39,671 11 payments
  4. TFN ADVANCED $31,914 29 payments
  5. CANNULATED SCREWS $8,775 3 payments
  6. EX NAILS $8,232 5 payments
  7. OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST $5,941 25 payments
  8. VA-LCP PLATES & SCREWS $4,405 3 payments
  9. IM NAILS $4,402 3 payments
  10. Unifi Technology $3,250 4 payments
  11. Other $8,771 92 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for Orthopedic Surgery: 203

Drug cost

$163

Median for Orthopedic Surgery: $1,433

Branded share of claims

100%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $163

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$74,846

Medicare's payments for the services billed

Medicare patients

107

Average age 77

Services billed

181

69 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Depression 49%
Osteoporosis 42%
Chronic kidney disease 40%
Ischemic heart disease 34%
Atrial fibrillation 32%
Diabetes 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

283 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record